[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Publications found: 1,153
Sort by:

Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018

US$ 2,000.00

... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2018 61 pages

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) development landscape Develop and design in-licensing and ...

April 2018 51 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2018

US$ 3,500.00

... Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2018 55 pages

Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

US$ 4,899.00

... segments the global monoclonal antibody therapeutics market as follows: Global Monoclonal Antibody Therapeutics Market: Application Segment Analysis Cancer Autoimmune Diseases Infection Hematological Diseases Others Global Monoclonal Antibody Therapeutics Market: Source Segment ...

April 2018 110 pages

Exploring Opportunities in Niche Therapies – Human Cytomegalovirus (HCMV) Infections

US$ 2,500.00

... for these patients. In this report we discuss the recently approved therapies for CMV infections, other drugs and vaccines in the pipeline ...

April 2018 42 pages

Global Cell Therapy Market, Price, Product & Clinical Pipeline Outlook 2024

US$ 2,400.00

... potential. Kuick Research Report on the Global cell therapy market provides a detailed insight into the current scenario of the cell therapy market worldwide. Key data like pricing of cell therapy products, cost analysis of cell therapy ...

April 2018 1200 pages

Hot and Cold Therapy Packs: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Hot and Cold Therapy Packs in US$ by the following Product Segments: Cold Packs, Hot Packs, Moist Therapy Packs, and Localized Heating/Cooling Pads. The ...

March 2018 249 pages

Global Brachytherapy Therapy Market 2018-2024

US$ 2,750.00

Global Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves ...

March 2018 99 pages

Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018

US$ 2,000.00

... . The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 260 pages

Cell Therapy Processing: Global Markets and Technologies

US$ 1,250.00

... in-depth analysis of the global cell therapy processing market by offering type, application and geographic regional markets. The report includes key inhibitors ... in the global cell therapy processing market. In-depth patent analysis in the report will provide extensive technological trends across years ...

March 2018 187 pages

Hemophilia B - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Hemophilia B (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hemophilia B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 126 pages

Choroidal Neovascularization - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 47 pages

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2018

US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 90 pages

Cedar Pollen Allergy - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Cedar Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cedar Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 36 pages

Bronchitis - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 68 pages

Ependymoma - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 149 pages

West Nile Virus Infections - Pipeline Review, H1 2018

US$ 2,000.00

... . The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 67 pages

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018

US$ 2,000.00

... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 36 pages

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018

US$ 3,500.00

... Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 58 pages

Atopic Dermatitis - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Atopic Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2018 379 pages

Scar - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Scar (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Scar and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2018 84 pages

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2018

US$ 2,000.00

... . The Alpha%li%Antitrypsin Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Alpha%li%Antitrypsin Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 84 pages

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) development landscape Develop ...

February 2018 61 pages

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) development landscape Develop and ...

February 2018 70 pages

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 33 pages

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 70 pages

Amyloidosis Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, deli...

February 2018 130 pages

Amyloidosis Therapeutics-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Amyloidosis Therapeutics-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, delivering...

February 2018 136 pages

Amyloidosis Therapeutics-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, delivering d...

February 2018 136 pages

Amyloidosis Therapeutics-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, delivering...

February 2018 149 pages

Amyloidosis Therapeutics-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Amyloidosis Therapeutics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, delivering...

February 2018 137 pages

Amyloidosis Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report Amyloidosis Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? per...

February 2018 143 pages

Amyloidosis Therapeutics-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Amyloidosis Therapeutics-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, delivering...

February 2018 155 pages

Amyloidosis Therapeutics-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, del...

February 2018 153 pages

Amyloidosis Therapeutics-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, del...

February 2018 145 pages

Amyloidosis Therapeutics-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Amyloidosis Therapeutics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Amyloidosis Therapeutics industry, standing on the readers? perspective, del...

February 2018 150 pages

Epistaxis Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, deliveri...

February 2018 139 pages

Epistaxis Therapeutics-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Epistaxis Therapeutics-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, delivering deta...

February 2018 150 pages

Epistaxis Therapeutics-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, delivering detai...

February 2018 147 pages

Epistaxis Therapeutics-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, delivering det...

February 2018 143 pages

Epistaxis Therapeutics-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Epistaxis Therapeutics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, delivering det...

February 2018 160 pages

Epistaxis Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report Epistaxis Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspec...

February 2018 150 pages

Epistaxis Therapeutics-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Epistaxis Therapeutics-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, delivering deta...

February 2018 135 pages

Epistaxis Therapeutics-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, deliver...

February 2018 141 pages

Epistaxis Therapeutics-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, deliver...

February 2018 135 pages

Epistaxis Therapeutics-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Epistaxis Therapeutics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Epistaxis Therapeutics industry, standing on the readers? perspective, deliver...

February 2018 141 pages

Hospital Infection Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Hospital Infection Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hospital Infection Therapeutics industry, standing on the readers? per...

February 2018 160 pages

Hospital Infection Therapeutics-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Hospital Infection Therapeutics-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hospital Infection Therapeutics industry, standing on the readers? perspectiv...

February 2018 151 pages

Hospital Infection Therapeutics-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Hospital Infection Therapeutics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hospital Infection Therapeutics industry, standing on the readers? perspective...

February 2018 146 pages

Hospital Infection Therapeutics-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Hospital Infection Therapeutics-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hospital Infection Therapeutics industry, standing on the readers? perspecti...

February 2018 135 pages

Filters

Search

Publishers

1
24
1
100
2
23
16
2
2
2
8
1
1
1
6
126
1
1
2
10
8
1
22
8
2
2
1
70
3
2
21
2
4
1
2
2
6
10
8
1
9
2
1
3
1
1
4
24
6
2
3
1
15
18
6
1
2
19
14
1
2
5
1
19
35
19
27
19
5
324
17
17
2
4
1
17

Regions

2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
5
2
1
2
1
1
2
2
1
1
1
1
1
1
1
3
2
1
1
1
1
1
3
1
1
1
1
1
3
2
10
1
17
14
1
13
4
3
2
2
2
2
3
2
2
19
2
2
3
12
10
4
32
918
1

Price

Date

Pages

Offers

100
22
1
1